CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome-Reference-Cited by-同舟云学术

CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome

Published:2021-09 Issue: Volume:225 Page:153567
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Koumpis Epameinondas^ORCID,Tassi Iliana^ORCID,Malea Theodora,Papathanasiou Konstantina,Papakonstantinou Ioannis^ORCID,Serpanou Anastasia,Tsolas Evangelos,Kapsali Eleni,Vassilakopoulos Theodoros P.,Papoudou-Bai Alexandra^ORCID,Hatzimichael Eleftheria^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference32 articles.

1. The assessment of CD56 and CD117 expressions at the time of the diagnosis in multiple myeloma patients;Ceran;Turk. J. Haematol.,2017

2. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system;Chang;Br. J. Haematol.,2005

3. Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant;Chang;Leuk. Lymphoma,2006

4. High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma;Dimopoulos;Ann. Intern Med,1991

5. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Dimopoulos;Hemasphere,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small cell carcinoma with neuroendocrine differentiation of subglottic larynx- a case report;Frontiers in Oncology;2023-09-25

2. La relación entre los parámetros inmunohistoquímicos, la fibrosis de la médula ósea y la captación de 18F-FDG en la médula ósea en pacientes con mieloma múltiple sometidos a examen PET/TC;Revista Española de Medicina Nuclear e Imagen Molecular;2023-09

3. MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS;Mediterranean Journal of Hematology and Infectious Diseases;2023-08-29

4. High Red Blood Cell Distribution Width to Platelet Ratio is an Independent Poor Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma;Discovery Medicine;2023

5. Biological Activity and Prognostic Significance of Common Surface Antigens in Multiple Myeloma;Advances in Clinical Medicine;2023